Literature DB >> 21771153

Noonan syndrome.

Anne M Turner1.   

Abstract

Noonan syndrome is a common autosomal dominant condition, readily recognisable in childhood. It is characterised by a pattern of typical facial dysmorphism and malformations including congenital cardiac defects, short stature, abnormal chest shape, broad or webbed neck, and a variable learning disability. Mildly affected adults may not be diagnosed until the birth of a more obviously affected child. The phenotype is highly variable. Important progress in understanding the molecular basis of this and other related conditions was made in 2001 when germline mutations in the PTPN11 gene were found to account for ∼50% of cases. Since then, mutations in additional genes in the rat sarcoma (RAS) pathway have been identified in a proportion of the remainder. Molecular confirmation of diagnosis is now possible for many families and has become increasingly important in guiding management. Increased awareness by paediatricians will lead to earlier diagnosis, and provide patients and their families with accurate genetic counselling, including options when planning pregnancy.
© 2011 The Author. Journal of Paediatrics and Child Health © 2011 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Keywords:  Noonan syndrome; PTPN11; autosomal dominant; congenital heart defect; short stature

Mesh:

Substances:

Year:  2011        PMID: 21771153     DOI: 10.1111/j.1440-1754.2010.01970.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  6 in total

1.  First Report of Congenital Short Bowel Syndrome in an Iranian Patient Caused by a Mutation in the CLMP Gene.

Authors:  Jalal Gharesouran; Behnaz Salek Esfahani; Saeed Farajzadeh Valilou; Mohsen Moradi; Mir Hadi Mousavi; Maryam Rezazadeh
Journal:  J Pediatr Genet       Date:  2018-10-26

2.  Intramolecular Interaction with the E6 Region Stabilizes the Closed Conformation of the N-SH2 Domain and Concurs with the Self-Inhibitory Docking in Downregulating the Activity of the SHP2 Tyrosine Phosphatase: A Molecular Dynamics Study.

Authors:  Emanuele Bellacchio
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

3.  Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome.

Authors:  Nehla Ghedira; Arnaud Lagarde; Karim Ben Ameur; Sahar Elouej; Rania Sakka; Emna Kerkeni; Fatma-Zohra Chioukh; Sylviane Olschwang; Jean-Pierre Desvignes; Sonia Abdelhak; Valerie Delague; Nicolas Lévy; Kamel Monastiri; Annachiara De Sandre-Giovannoli
Journal:  BMC Pediatr       Date:  2018-08-29       Impact factor: 2.125

4.  Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review.

Authors:  Diane J Nugent; Alicia A Romano; Shreya Sabharwal; David L Cooper
Journal:  J Blood Med       Date:  2018-10-23

5.  Social cognitive training for adults with Noonan syndrome: a feasibility study.

Authors:  Renée L Roelofs; Ellen Wingbermühle; Roy P C Kessels; Jos I M Egger
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-26       Impact factor: 2.570

6.  Noonan syndrome with RAF1 gene mutations in a newborn with cerebral haemorrhage.

Authors:  Junwei Lan; Tianbao Zeng; Sheng Liu; Juhong Lan; Lijun Qian
Journal:  Eur J Med Res       Date:  2022-08-11       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.